All Stories

  1. Lollipop Plots to Communicate Cost-Effectiveness Scenario Analyses Results

    Article • PharmacoEconomics, October 2025, Springer Science + Business Media

    Isaac Corro Ramos

  2. Reply to Comment on “Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective”

    Article • PharmacoEconomics, October 2025, Springer Science + Business Media

    Isaac Corro Ramos

  3. The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands

    Article • Value in Health, September 2025, Elsevier

    Isaac Corro Ramos

  4. Cost Comparisons in NICE Technology Appraisals: An External Assessment Group Perspective

    Article • PharmacoEconomics, July 2025, Springer Science + Business Media

    Isaac Corro Ramos

  5. When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal

    Article • PharmacoEconomics, May 2025, Springer Science + Business Media

    Isaac Corro Ramos

  6. Under-reporting of Validation Efforts for Health Economic Models Persists Despite the Availability of Validation Tools: A Systematic Review

    Article • PharmacoEconomics, April 2025, Springer Science + Business Media

    Isaac Corro Ramos

  7. The Cost-Effectiveness of Seizure Dogs for Persons Living With Severe Refractory Epilepsy: Results From the EPISODE Study

    Article • Value in Health, December 2024, Elsevier

    Isaac Corro Ramos

  8. Beyond hazard ratios: appropriate statistical methods for quantifying the clinical effectiveness of immune-oncology therapies – the example of the Netherlands

    Article • BMC Medical Research Methodology, October 2024, Springer Science + Business Media

    Isaac Corro Ramos

  9. A cloud-based medical device for predicting cardiac risk in suspected coronary artery disease: a rapid review and conceptual economic model

    Article • Health Technology Assessment, July 2024, National Institute for Health Research

    Isaac Corro Ramos

  10. Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy

    Article • Neurology, March 2024, Wolters Kluwer Health

    Isaac Corro Ramos

  11. Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling

    Article • PharmacoEconomics, March 2024, Springer Science + Business Media

    Isaac Corro Ramos

  12. A blueprint for health technology assessment capacity building: lessons learned from Malta

    Article • International Journal of Technology Assessment in Health Care, January 2024, Cambridge University Press

    Isaac Corro Ramos

  13. SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis

    Article • Health Technology Assessment, November 2022, National Institute for Health Research

    Isaac Corro Ramos

  14. Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness Analysis

    Article • JMIR Cardio, August 2022, JMIR Publications Inc.

    Isaac Corro Ramos

  15. The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis

    Article • Value in Health, August 2022, Elsevier

    Isaac Corro Ramos

  16. Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial

    Article • Clinical Drug Investigation, January 2022, Springer Science + Business Media

    Isaac Corro Ramos

  17. Four Aspects Affecting Health Economic Decision Models and Their Validation

    Article • PharmacoEconomics, December 2021, Springer Science + Business Media

    Isaac Corro Ramos

  18. Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure

    Article • Value in Health, October 2021, Elsevier

    Isaac Corro Ramos

  19. Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy

    Article • Value in Health, October 2021, Elsevier

    Isaac Corro Ramos

  20. Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study

    Article • BMJ Open, August 2021, BMJ

    Isaac Corro Ramos

  21. Cost-effectiveness of a home telemonitoring system and a diagnostic algorithm in the management of heart failure in the Netherlands (Preprint)

    Article • June 2021, JMIR Publications Inc.

    Isaac Corro Ramos

  22. Cost-utility analysis of four common surgical treatment pathways for breast cancer

    Article • European Journal of Surgical Oncology, June 2021, Elsevier

    Isaac Corro Ramos

  23. How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease

    Article • Medical Decision Making, July 2020, SAGE Publications

    Isaac Corro Ramos

  24. Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients

    Article • The European Journal of Health Economics, January 2020, Springer Science + Business Media

    Isaac Corro Ramos

  25. Evaluating the Effectiveness and Cost-Effectiveness of Seizure Dogs in Persons With Medically Refractory Epilepsy in the Netherlands: Study Protocol for a Stepped Wedge Randomized Controlled Trial (EPISODE)

    Article • Frontiers in Neurology, January 2020, Frontiers

    Isaac Corro Ramos

  26. What Is the Potential of Tissue-Engineered Pulmonary Valves in Children?

    Article • The Annals of Thoracic Surgery, June 2019, Elsevier

    Isaac Corro Ramos

  27. Severity-Adjusted Probability of Being Cost Effective

    Article • PharmacoEconomics, May 2019, Springer Science + Business Media

    Isaac Corro Ramos

  28. Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine

    Article • Value in Health, March 2019, Elsevier

    Isaac Corro Ramos

  29. Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2019, Dove Medical Press

    Isaac Corro Ramos, Laura Luciani

  30. Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

    Article • PharmacoEconomics, December 2018, Springer Science + Business Media

    Isaac Corro Ramos

  31. PRM120 - GRAPHICAL USER-FRIENDLY INTERFACE FOR COMPLEX HEALTH ECONOMIC MODELS BUILT IN R

    Article • Value in Health, October 2018, Elsevier

    Isaac Corro Ramos

  32. PRS49 - COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM + OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE

    Article • Value in Health, October 2018, Elsevier

    Isaac Corro Ramos

  33. PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES IN THE AORTIC POSITION IN ELDERLY PATIENTS

    Article • Value in Health, October 2018, Elsevier

    Isaac Corro Ramos

  34. PHP142 - SEVERITY ADJUSTED PROBABILITY OF BEING COST-EFFECTIVE: A NOVEL APPROACH TO INTEGRATE SEVERITY AND COST-EFFECTIVENESS WITH APPLICATIONS TO NORWAY AND THE NETHERLANDS

    Article • Value in Health, October 2018, Elsevier

    Isaac Corro Ramos

  35. Cost-effectiveness of the fixed-dose combination tiotropium + olodaterol based on the DYNAGITO trial results

    Article • September 2018, European Respiratory Society (ERS)

    Isaac Corro Ramos

  36. The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios

    Article • BMC Family Practice, February 2018, Springer Science + Business Media

    Isaac Corro Ramos

  37. Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmaco...

    Article • Value in Health, December 2017, Elsevier

    Isaac Corro Ramos

  38. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance

    Article • BMC Medicine, October 2017, Springer Science + Business Media

    Isaac Corro Ramos

  39. Early Modelling of The Cost-Effectiveness of Stratified Medicine In COPD

    Article • Value in Health, October 2017, Elsevier

    Isaac Corro Ramos

  40. Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research

    Article • PharmacoEconomics, September 2017, Springer Science + Business Media

    Isaac Corro Ramos

  41. Modeling the cost-effectiveness of stratified medicine in COPD

    Article • September 2017, European Respiratory Society (ERS)

    Isaac Corro Ramos

  42. A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

    Article • Value in Health, May 2017, Elsevier

    Isaac Corro Ramos

  43. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis

    Article • Health Technology Assessment, May 2017, National Institute for Health Research

    Isaac Corro Ramos

  44. Estimating Study Costs For Use In Voi, A Study Of Dutch Publicly Funded Drug Related Research

    Article • Value in Health, November 2016, Elsevier

    Isaac Corro Ramos

  45. The Increasing Importance of A Continence Nurse Specialist To Improve Outcomes And Save Costs of Urinary Incontinence Care: An Analysis of Future Policy Scenarios

    Article • Value in Health, November 2016, Elsevier

    Isaac Corro Ramos

  46. Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework

    Article • Medical Decision Making, July 2016, SAGE Publications

    Isaac Corro Ramos

  47. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evalua...

    Article • Health Technology Assessment, February 2016, National Institute for Health Research

    Isaac Corro Ramos

  48. AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users

    Article • PharmacoEconomics, December 2015, Springer Science + Business Media

    Isaac Corro Ramos

  49. Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives

    Article • PharmacoEconomics, November 2015, Springer Science + Business Media

    Isaac Corro Ramos

  50. Operational Validation of Health Economic Decision Analytic Models

    Article • Value in Health, November 2015, Elsevier

    Isaac Corro Ramos

  51. The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling

    Article • Applied Health Economics and Health Policy, September 2015, Springer Science + Business Media

    Isaac Corro Ramos

  52. Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia

    Article • Value in Health Regional Issues, September 2015, Elsevier

    Isaac Corro Ramos

  53. Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

    Article • Cancer Management and Research, August 2015, Dove Medical Press

    Dr Olena Mandrik, Isaac Corro Ramos

  54. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis

    Article • Health Technology Assessment, July 2015, National Institute for Health Research

    Isaac Corro Ramos

  55. Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis

    Article • Value in Health, January 2015, Elsevier

    Isaac Corro Ramos

  56. Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis

    Article • Value in Health, November 2014, Elsevier

    Isaac Corro Ramos

  57. Advishe: a New Tool to Report Validation of Health-Economic Decision Models

    Article • Value in Health, November 2014, Elsevier

    Isaac Corro Ramos

  58. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis

    Article • Health Technology Assessment, December 2013, National Institute for Health Research

    Isaac Corro Ramos

  59. Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine

    Article • Value in Health Regional Issues, September 2013, Elsevier

    Isaac Corro Ramos

  60. Improving Model Validation in Health Technology Assessment: Comments on Guidelines of the ISPOR-SMDM Modeling Good Research Practices Task Force

    Article • Value in Health, September 2013, Elsevier

    Isaac Corro Ramos

  61. Dead-locks and Break of Symmetry in Robot Coordination

    Article • March 2013, Wiley

    Isaac Corro Ramos

  62. The Role of Value-of-Information Analysis in a Health Care Research Priority Setting

    Article • Medical Decision Making, December 2012, SAGE Publications

    Isaac Corro Ramos

  63. VI1 Determining the Impact of Modeling Additional Sources of Uncertainty in Value of Information Analysis

    Article • Value in Health, November 2011, Elsevier

    Isaac Corro Ramos

  64. PHP104 Identifying Factors Influencing Drug Reimbursement in Scotland

    Article • Value in Health, November 2011, Elsevier

    Isaac Corro Ramos

  65. PHP87 THE ROLE OF VALUE OF INFORMATION ANALYSIS IN HEALTH CARE RESEARCH PRIORITY SETTING:A THEORETICAL CASE STUDY

    Article • Value in Health, November 2010, Elsevier

    Isaac Corro Ramos

  66. Model Driven Testing Based on Test History

    Article • January 2008, Springer Science + Business Media

    Isaac Corro Ramos

  67. Two Case Studies in Applying Statistical Models in Software Development

    Article • Quality Engineering, October 2007, Taylor & Francis

    Isaac Corro Ramos